Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 08:34 am Sale | 13G | Forma Therapeutics Holdings Inc. FMTX | Deep Track Capital LP | 0 0.000% | -2,686,655 (Position Closed) | View |
| 2022-10-14 4:03 pm Sale | 13D | Forma Therapeutics Holdings Inc. FMTX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -9,040,309 (Position Closed) | View |
| 2022-09-02 4:30 pm Purchase | 13D | Forma Therapeutics Holdings Inc. FMTX | RA CAPITAL MANAGEMENT L.P. | 9,040,309 18.880% | 11,125 (+0.12%) | View |
| 2022-06-03 4:12 pm Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | Deep Track Capital LP | 2,686,655 5.620% | 2,686,655 (New Position) | View |
| 2022-05-10 10:13 am Sale | 13G | Forma Therapeutics Holdings Inc. FMTX | FMR LLC | 222,990 0.492% | -3,654,062 (-94.25%) | View |
| 2022-02-14 3:13 pm Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | Cormorant Asset Management LP | 4,639,998 9.790% | 179,998 (+4.04%) | View |
| 2022-02-11 4:31 pm Sale | 13G | Forma Therapeutics Holdings Inc. FMTX | Novartis Bioventures Ltd | 1,757,057 3.710% | -1,234,648 (-41.27%) | View |
| 2022-02-10 4:29 pm Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | ELI LILLY & Co LLY | 339,191 0.700% | 339,191 (New Position) | View |
| 2022-02-10 08:11 am Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | VANGUARD GROUP INC | 2,860,653 6.030% | 2,860,653 (New Position) | View |
| 2022-02-09 09:19 am Sale | 13G | Forma Therapeutics Holdings Inc. FMTX | FMR LLC | 3,877,052 8.178% | -873,437 (-18.39%) | View |
| 2022-02-03 4:41 pm Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | BlackRock Inc. BLK | 3,026,666 6.400% | 391,916 (+14.87%) | View |
| 2021-10-28 4:32 pm Purchase | 13D | Forma Therapeutics Holdings Inc. FMTX | RA CAPITAL MANAGEMENT L.P. | 9,029,184 19.050% | 17,533 (+0.19%) | View |
| 2021-03-10 09:46 am Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | FMR LLC | 4,750,489 10.615% | 634,841 (+15.43%) | View |
| 2021-02-16 3:06 pm Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | Cormorant Asset Management LP | 4,460,000 9.970% | 1,080,630 (+31.98%) | View |
| 2021-02-12 5:16 pm Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | Lilly Ventures Fund I LLC | 2,404,069 5.200% | 2,404,069 (New Position) | View |
| 2021-02-08 10:21 am Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | FMR LLC | 4,115,648 9.196% | 4,115,648 (New Position) | View |
| 2021-02-02 3:16 pm Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | BlackRock Inc. BLK | 2,634,750 5.700% | 2,634,750 (New Position) | View |
| 2021-02-01 4:09 pm Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | Novartis Bioventures Ltd | 2,991,705 6.690% | 2,991,705 (New Position) | View |
| 2020-07-06 4:01 pm Purchase | 13G | Forma Therapeutics Holdings Inc. FMTX | Cormorant Asset Management LP | 3,379,370 8.760% | 3,379,370 (New Position) | View |
| 2020-06-25 5:02 pm Purchase | 13D | Forma Therapeutics Holdings Inc. FMTX | RA CAPITAL MANAGEMENT L.P. | 9,011,651 23.400% | 9,011,651 (New Position) | View |